Is there a role for uric acid in an animal model of calcium phosphate nephrocalcinosis and calcium phosphate crystallization in urine of patients with idiopathic calcium urolithiasis? An orientational study

Journal of Endourology

Volumn 13, Issue 9, 1999, Pages 637-645

  Schwille, Paul O ^a   Schmiedl, A ^b   Manoharan, M ^b   Wipplinger, J ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; URIC ACID; XANTHINE OXIDASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CRYSTALLIZATION; DISEASE ASSOCIATION; HUMAN; HYPERURICOSURIA; KIDNEY CALCIFICATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STONE FORMATION; UROLITHIASIS;

EID: 0032787019     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.1999.13.637     Document Type: Article

References (39)

1. Fellström B. Urate metabolism and renal calcium stone disease. Scand J Urol Nephrol 1981;Suppl 62:6-44.
2. Grover P, Ryall R. Urate and calcium oxalate stones: From repute to rhetoric to reality. Miner Electrol Metab 1994;20:361-370.
3. Ettinger B. Does hyperuricosuria play a role in calcium oxalate lithiasis? J Urol 1989;141:738-741.
4. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA 1981;78:6858-6862.
5. Reaven G. Role of insulin resistance in human disease: Banting Lecture. Diabetes 1988;37:1595-1607.
6. Schwille PO, Samberger NM, Wach B. Fasting uric acid and phosphate in urine and plasma of renal calcium-stone formers. Nephron 1976;16:116-125.
7. Stout RH, Akin RH, Norton E. Nephrocalcinosis in routine necropsies: Its relationship to stone formation. J Urol 1955;74:8-12.
8. Drach GW, Boyce WH. Nephrocalcinosis as a source for renal stone nuclei. J Urol 1972;107:897-900.
9. Kallistratos G. Physico-chemical principles and clinical results concerning the conservative treatment of kidney stones. Urol Int 1974;29:93-113.
10. Larsson L, Sörbo B, Tiselius HG, Ohman S. A method for quantitative wet-chemical analysis of urinary calculi. Clin Chim Acta 1984;140:9-14.
11. Schwille PO, Brandt P, Ulbrich D, Kömpf W. Pankreasinseln Plasma-Glucagon und renale Verkalkungen unter verschiedener GrunddiÑt bei der Ratte. Urologe A 1975;14:306-314.
12. Schmiedl A, Schwille PO, Bergé B, Markovic M, Dvorak O. Reappraisal of the quantity and nature of renal calcifications, and mineral metabolism in the magnesium-deficient rat: Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate. Urol Int 1998;61:76-85.
13. Schmiedl A, Bergé B, Bonucci E, Schwille PO, Grajczyk A. Nephrocalcinosis and hyperoxaluria in the rat fed an atherogenic diet. This article appeared in: Kidney Stones, Borglic L, Resclei T, Briganti A, Schianchi T, Novarich A (eds), Editoriale Bios, Cosenza/Italy, pp 461-463, 1999.
14. Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Yamakita J, Higashino K. Is the plasma uridine level a marker of the overproduction of uric acid? Metabolism 1997;46:801-804.
15. +-adenosine transport in rat renal brush border membranes. Int J Pharmaceut 1998;169:163-174.
16. Harkness RA. Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP depletion. J Chromatogr Biomed Appl 1988;429: 255-278.
17. Saugstad OD. Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr Res 1988;323:143-150.
18. Buhl MR, Buhl L. Uric acid accumulated in isolated kidney grafts: An assessment of agonal ischaemia. Int Urol Nephrol 1979;11: 229-237.
19. Parks DA, Granger DN. Ischemia-induced vascular changes: Role of xanthine oxidase and hydroxyl radicals. Am J Physiol 1983;245: G 285-G289.
20. Decker EA. High fat meals and endothelial function. Nutr Rev 1998;56:182-185.
21. Schwille PO, Rümenapf G, Köhler R. Blood levels of glucometabolic hormones and urinary saturation with stone-forming phases after an oral test meal in male patients with recurrent idiopathic calcium urolithiasis and in healthy controls. J Am Coll Nutr 1989;8:557-565.
22. Schwille PO, Schmiedl A, Herrmann U, Wipplinger J. Postprandial hyperinsulinemia, insulin resistance, and inappropriately high phosphaturia are features of younger males with idiopathic calcium urolithiasis: Attenuation by ascorbic acid supplementation of the test meal. Urol Res 1996;25:49-58.
23. Schwille PO, Herrmann U, Schmiedl A, Kissler H, Wipplinger J, Manoharan M. Urinary phosphate excretion in the pathophysiology of idiopathic recurrent calcium urolithiasis: Hormonal interactions and lipid metabolism. Urol Res 1997;25:417-426.
24. Facchini F, Chen IYD, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA 1991;266:3008-3011.
25. Garbagnati E. Urate changes in lean and obese boys during pubertal development. Metabolism 1996;45:203-205.
26. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid: A facet of hyperinsulinemia. Diabetologia 1987;30:713-718.
27. Bracci R. Calcium involvement in free radical effects. Calcif Tiss Int 1992;51:401-405.
28. Salahudeen AK, Clark EC, Nath KA. Hydrogen peroxide-induced renal injury: A protective role for pyruvate in vitro and in vivo. J Clin Invest 1991;88:1886-1893.
29. Ha H, Endou H. Lipid peroxidation in isolated rat nephron segments. Am J Physiol 1992;263:F201-F207.
30. Arduini A, Storto S, Belfiglio M. Mechanism of spectrin degradation induced by phenylhydrazine in intact human erythrocytes. Biochim Biophys Acta 1989;979:1-6.
31. Hise MK, Mantulin WW, Weinman EJ. Fluidity, and composition of brush border and basolateral membranes from rat kidney. Am J Physiol 184;247:F434-F437.
32. Fan J, Schwille PO, Manoharan M, Gottlieb D, Schmiedl A. Calcium oxalate nucleation, growth and aggregation in undiluted urine of healthy controls and patients with idiopathic calcium urolithiasis evaluated by a one-time small-volume test procedure: Effects of alkali citrate. Clin Lab 1995;41:139-144.
33. Jacob RA. The integrated antioxidant system. Nutr Res 1995; 15:755-766.
34. Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997;46: 1162-1165.
35. Kieling U, Spiteller G. The cause of enzymatically induced lipid peroxidation in homogenized porcine kidney tissue. Z Naturforsch 1998;53c:431-437.
36. McKee MD, Nanci A, Khan SR. Ultrastructural immuno-detection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Min Res 1995;10:1913-1929.
37. Schwille PO, Schmiedl A, Herrmann U, Bergé B, Kissler H, Rümenapf G. Phosphaturia and the associated metabolic activity in idiopathic recurrent calcium urolithiasis (RCU) reexamined: What do they tell us? In: Tiselius HG (ed): Renal Stones: Aspects of Their Formation, Removal and Prevention. Edsbruk, Akademytryck AB, 1996, pp 86-88.
38. Engle JE, Steele TH. Variation of urate excretion with urine flow in normal man. Nephron 1976;16:50-56.
39. Angermüller S, Schunk M, Kusterer K. Alteration of xanthine oxidase activity in sinusoidal endothelial cells and morphological changes of Kupffer cells in hypoxic and reoxygenated rat liver. Hepatology 1995;21:1594-1601.